Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

CELL

PhenomeX (CELL)

PhenomeX Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CELL
FechaHoraFuenteTítuloSímboloCompañía
08/02/202416:58Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CELLPhenomeX Inc
12/10/202308:00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:CELLPhenomeX Inc
03/10/202314:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELLPhenomeX Inc
02/10/202316:16Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:CELLPhenomeX Inc
02/10/202316:06Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CELLPhenomeX Inc
02/10/202307:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELLPhenomeX Inc
29/09/202307:30Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:CELLPhenomeX Inc
27/09/202307:51PR Newswire (US)PhenomeX Announces Opto® Memory B Discovery Human Workflow on the Beacon® Optofluidic PlatformNASDAQ:CELLPhenomeX Inc
21/09/202307:35PR Newswire (US)PhenomeX Announces the Release of SpotLight™ Human Lambda Reagent for the Beacon® Platform to Accelerate Cell Line Development WorkflowsNASDAQ:CELLPhenomeX Inc
20/09/202307:48PR Newswire (US)PhenomeX to Participate in Upcoming Cell Biology ConferencesNASDAQ:CELLPhenomeX Inc
15/09/202308:08PR Newswire (US)PhenomeX Unveils Meteor™ Chips For Quantitative Bulk Analysis On The IsoSpark™ Platform To Revolutionize High Throughput Multiplexed Hands-Free ProteomicsNASDAQ:CELLPhenomeX Inc
05/09/202315:02PR Newswire (US)PhenomeX Inc. Announces Commencement of Cash Tender Offer by BrukerNASDAQ:CELLPhenomeX Inc
31/08/202315:47Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:CELLPhenomeX Inc
28/08/202316:04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CELLPhenomeX Inc
18/08/202316:21Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CELLPhenomeX Inc
17/08/202308:00Business WireBruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash TransactionNASDAQ:CELLPhenomeX Inc
14/08/202315:23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CELLPhenomeX Inc
14/08/202315:05PR Newswire (US)PhenomeX Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:CELLPhenomeX Inc
09/08/202315:25PR Newswire (US)PhenomeX to Report Second Quarter 2023 Financial Results on August 14, 2023NASDAQ:CELLPhenomeX Inc
07/08/202307:11PR Newswire (US)PhenomeX Announces Lifting of the Stay in AbCellera Patent Infringement CaseNASDAQ:CELLPhenomeX Inc
26/07/202317:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CELLPhenomeX Inc
23/06/202315:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CELLPhenomeX Inc
13/06/202308:32PR Newswire (US)PhenomeX's Beacon® Technology Enables Early Identification of Potent Omicron-Neutralizing AntibodiesNASDAQ:CELLPhenomeX Inc
05/06/202307:46PR Newswire (US)PhenomeX Launches Beacon Quest™ Optofluidic System with Opto® T Cell Profiling WorkflowsNASDAQ:CELLPhenomeX Inc
01/06/202315:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELLPhenomeX Inc
15/05/202315:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CELLPhenomeX Inc
15/05/202308:01PR Newswire (US)PhenomeX Launches Beacon Select™ Optofluidic System with Opto® B Discovery WorkflowsNASDAQ:CELLPhenomeX Inc
11/05/202315:02PR Newswire (US)PhenomeX Reports First Quarter 2023 Financial ResultsNASDAQ:CELLPhenomeX Inc
11/05/202308:35PR Newswire (US)PhenomeX To Participate in 19th Annual PEGS Boston Conference & ExpoNASDAQ:CELLPhenomeX Inc
05/05/202310:54Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CELLPhenomeX Inc
 Showing the most relevant articles for your search:NASDAQ:CELL